BOLT vs CE · rev $7.7M vs rev $10.28B
Bolt Biotherapeutics (BOLT) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BOLT currently screens at market cap $11.3M. CE currently screens at market cap $5.92B.
Not investment advice. Open the BOLT and CE stock pages for the full models.
Not investment advice.